Sander P, Prammananan T, Meier A, Frischkorn K, Böttger E C
Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany. Boettger.Erik Mh-Hannover.de
Mol Microbiol. 1997 Nov;26(3):469-80. doi: 10.1046/j.1365-2958.1997.5811946.x.
Macrolides are bacteriostatic antibiotics which interfere with the peptidyltransfer function of the ribosome. We have investigated the molecular mechanisms underlying macrolide resistance in Mycobacterium smegmatis, an eubacterium carrying two rRNA operons. Surprisingly, drug resistance was associated not with alterations in ribosomal proteins, but with a single point mutation in the peptidyltransferase region of one of the two 23S RNA genes, i.e. A2058-->G or A2059-->G. This mutation resulted in a heterozygous organism with a mutated and a wild-type rRNA operon respectively. Reverse transcriptase sequencing indicated the expression of both wild-type and mutated rRNAs. The mutated operon was introduced into genetically engineered rrn- strains of M. smegmatis carrying a single functional rRNA operon and into parental M. smegmatis with two chromosomal rRNA operons, using gene transfer as well as gene replacement techniques. The results obtained demonstrate the dominant nature of resistance. As exemplified in our results on macrolide resistance, a complete set of genetic tools is now available, which allows questions of dominance vs. recessivity and gene dosage effects in eubacterial ribosomal nucleic acids to be addressed experimentally in vivo.
大环内酯类是一类抑菌性抗生素,可干扰核糖体的肽基转移功能。我们研究了耻垢分枝杆菌(一种带有两个rRNA操纵子的真细菌)中大环内酯耐药性的分子机制。令人惊讶的是,耐药性并非与核糖体蛋白的改变相关,而是与两个23S RNA基因之一的肽基转移酶区域中的单个点突变有关,即A2058→G或A2059→G。这种突变导致了一种杂合生物体,分别具有一个突变的和一个野生型的rRNA操纵子。逆转录酶测序表明野生型和突变型rRNA均有表达。利用基因转移和基因置换技术,将突变的操纵子导入携带单个功能性rRNA操纵子的耻垢分枝杆菌基因工程rrn-菌株以及具有两个染色体rRNA操纵子的亲本耻垢分枝杆菌中。所获得的结果证明了耐药性的显性性质。正如我们关于大环内酯耐药性的结果所示,现在有一套完整的遗传工具,这使得在体内通过实验解决真细菌核糖体核酸中的显性与隐性问题以及基因剂量效应成为可能。